Energy and Commerce Committee
- Referred To
Introduced: Feb 21, 2025
Latest action date: Feb 21, 2025
Latest development
Referred to the House Committee on Energy and Commerce.
Civixly approval
No ratings yet
Not enough ratings yet. Public approval appears at 5+ ratings.
Status detail: The most advanced recorded stage is committee consideration.
Plain-language overview
This bill prohibits the use of federal funds to implement, administer, or enforce the final rule issued by the Food and Drug Administration (FDA) titled Medical Devices; Laboratory Developed Tests and published on May 6, 2024, or any substantially similar rule.
The rule specifies that laboratory developed tests (medical screening tests developed by laboratories rather than medical device manufacturers) are medical devices subject to FDA regulation with limited exceptions. Prior to the rule, the FDA had exercised discretion as to whether to apply regulations for medical devices to laboratory developed tests.
Official summary from Congress.gov.
Civixly topics
Civixly topics make federal and state legislation comparable. They are derived from the official CRS policy area and legislative subjects.
Official CRS policy area
Health
Committees and subcommittees that received, reviewed, marked up, or reported this legislation.
Proposed changes to this measure, with their latest official outcome or action from Congress.gov.
No amendments are listed for this measure.
Checked against Congress.gov Oct 23, 2026.
Newest action first. Action language comes from the official Congress.gov record.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Recorded House and Senate votes connected to this bill. Your representatives appear first when available.
No connected roll-call votes are currently available for this bill.
0 comments across 0 threads
Loading comments...